ABPI joins the Sustainable Medicines Partnership

YewMaker, the executive lead of the Sustainable Medicines Partnership (SMP), is announcing that the Association of the British Pharmaceutical Industry (ABPI) has joined as a founding Collaborator.

The SMP is a not-for-profit private-public collaboration executing projects to make the use of medicines more sustainable and less wasteful.

The ABPI is the trade association representing research-based pharmaceutical companies in the UK.

In its collaboration with the SMP, ABPI will collaborate on projects reducing waste, for example by reducing single-use plastics in medicines packaging, and the amount of paper used, by increasing digital medicines information.

The ABPI is delighted to join the Sustainable Medicines Partnership. Our members are already taking significant action to reduce their environmental footprint, including cutting carbon emissions, reducing waste, and saving water.

“The SMP is an important opportunity to bring together programmes and collaborators across the healthcare sector and to continue the drive to develop medicines in the most environmentally sustainable way possible.
— Steve Hoare, Quality, Regulatory Science and Safety Policy Director
Innovations in sustainable development, manufacture, distribution, and disposal of medicines are central to the mission of the SMP and will be driven by companies, represented by the ABPI, developing the medicines of the future. We are therefore delighted the ABPI have joined the SMP.
— Nazneen Rahman, YewMaker CEO, SMP Director

Posted 07/09/22

-End

 

Contacts:

YewMaker: comms@yewmaker.com

ABPI: pressoffice@abpi.org.uk

About the Sustainable Medicines Partnership
The SMP is a not-for-profit, private-public, multi-stakeholder collaboration. Through executing priority actions, the Sustainable Medicines Partnership aims to stop the avoidable waste of medicines and medicines packaging - reducing healthcare emissions and increasing health equity globally. Learn more at www.yewmaker.com/smp

About YewMaker
YewMaker builds science-based, scalable concepts and solutions that make healthcare more sustainable. YewMaker is the initiator and executive lead of the Sustainable Medicines Partnership. Learn more at www.yewmaker.com

About the Association of the British Pharmaceutical Industry
The ABPI exists to make the UK the best place in the world to research, develop and use new medicines and vaccines. We represent companies of all sizes who invest in discovering the medicines of the future.

Our members supply cutting edge treatments that improve and save the lives of millions of people. We work in partnership with Government and the NHS so patients can get new treatments faster and the NHS can plan how much it spends on medicines.

Every day, we partner with organisations in the life sciences community and beyond to transform lives across the UK. Learn more at www.abpi.org.uk

 

 

Previous
Previous

Sustainable Medicines Packaging Award Winners

Next
Next

BGMA joins the Sustainable Medicines Partnership